| Literature DB >> 35987626 |
Wei Chen1, Qixiang Fang1, Haomin Ren2, Lei Ma2, Jin Zeng1, Shangshu Ding3, Dapeng Wu4.
Abstract
BACKGROUND: Retroperitoneal robotic partial nephrectomy is markedly restricted by limited space and visual field. We introduced a novel Gerota-edge-sling (GES) technique with self-designed traction devices to overcome these defects by attaching Gerota fascia to abdominal wall, and comparatively evaluated its utilization with routine technique.Entities:
Keywords: Kidney neoplasms; Partial nephrectomy; Retroperitoneal approach; Robotic surgical procedures; Surgical technique
Mesh:
Year: 2022 PMID: 35987626 PMCID: PMC9392922 DOI: 10.1186/s12894-022-01079-4
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.090
Fig. 1The diagrams of GES technique. a Composition of the traction device. Straight needle with polypropylene suture fastened with silica gel tube. b GES technique scheme
Fig. 2The procedure of setting GES device and the effect. a Surgical vision before using GES technique. b Straight needle penetrating through the edge of Gerota fascia to abdominal wall. c Silica gel tube pulled to support the attachment of Gerota fascia to abdominal wall. d Surgical vision after using GES technique
Patient demographics, operative and tumor characteristics, stratified according to surgical techniques
| Control group | GES group | ||
|---|---|---|---|
| N = 48 | N = 55 | ||
| Mean ± SD age (ys) | 54.7 ± 12.7 | 53.3 ± 12.6 | 0.57 |
| Gender | 0.22 | ||
| No. male (%) | 39 (81.3) | 39 (70.9) | |
| No. female (%) | 9 (18.7) | 16 (29.1) | |
| No. laterality (%) | 0.53 | ||
| R | 30 (62.5) | 31 (56.4) | |
| L | 18 (37.5) | 24 (43.6) | |
| No. Anterior/posterior tumors (%) | 0.57 | ||
| Anterior | 25 (52.1) | 26 (46.4) | |
| Posterior | 23 (47.9) | 30 (53.6) | |
| Mean ± SD BMI (kg/m2) | 25.2 ± 2.8 | 24.3 ± 3.7 | 0.18 |
| Mean ± SD ASA score | 2.1 ± 0.5 | 2.0 ± 0.5 | 0.29 |
| Mean ± SD Charlson comorbidity index | 1.9 ± 1.6 | 2.0 ± 1.2 | 0.76 |
| Mean ± SD Console time (mins) | 117 ± 41 | 91 ± 36 | < 0.01 |
| Mean ± SD DT (mins) | 93 ± 38 | 67 ± 35 | < 0.01 |
| Mean ± SD WIT (mins) | 21.3 ± 5.0 | 20.6 ± 4.2 | 0.46 |
| Mean ± SD EBL (ml) | 81 ± 92 | 74 ± 44 | 0.61 |
| Mean ± SD Length of stay after operation (days) | 4.3 ± 0.7 | 4.3 ± 0.9 | 0.44 |
| No. Clavien–Dindo complication (%) | 0.82 | ||
| None | 43 (89.6) | 48 (87.3) | |
| Grade I | 3 (6.3) | 5 (9.1) | |
| Grade II | 2 (4.1) | 2 (3.6) | |
| Mean ± SD tumor diameter (mm) | 35 ± 11 | 38 ± 10 | 0.29 |
| Mean ± SD R.E.N.A.L. score | 7.3 ± 1.8 | 7.4 ± 1.8 | 0.73 |
| No. R.E.N.A.L. complexity (%) | 0.85 | ||
| Low | 14 (29.2) | 16 (29.1) | |
| Moderate | 30 (62.5) | 33 (60.0) | |
| High | 4 (8.3) | 6 (10.9) | |
| Mean ± SD MAP score | 1.9 ± 1.6 | 2.2 ± 1.3 | 0.26 |
| No. histology (%) | 0.86 | ||
| Clear cell | 44 (91.7) | 50 (90.9) | |
| Papillary | 1 (2.1) | 0 (0) | |
| Chromophobe | 2 (4.1) | 3 (5.5) | |
| Other malignant | 1 (2.1) | 2 (3.6) | |
| No. pathological stage (%) | 0.86 | ||
| T1a | 31 (64.6) | 33 (60.0) | |
| T1b | 16 (33.3) | 22 (40.0) | |
| T2a | 1 (2.1) | 0 (0) |
L Left; R Right; No Number; SD Standard deviation
Subgroup comparison of perioperative characteristics between the two groups
| Control group | GES group | ||
|---|---|---|---|
| Mean ± SD BMI (kg/m2) | 25.1 ± 2.5 | 24.9 ± 3.4 | 0.80 |
| Mean ± SD Console time (mins) | 125 ± 43 | 92 ± 36 | < 0.01 |
| Mean ± SD DT (mins) | 100 ± 41 | 69 ± 35 | < 0.01 |
| Mean ± SD WIT (mins) | 22.0 ± 4.9 | 20.3 ± 4.3 | 0.18 |
| Mean ± SD EBL (ml) | 69 ± 48 | 66 ± 33 | 0.77 |
| Mean ± SD tumor diameter (mm) | 38 ± 12 | 36 ± 10 | 0.39 |
| Mean ± SD R.E.N.A.L. score | 7.6 ± 1.7 | 7.5 ± 1.6 | 0.83 |
| Mean ± SD MAP score | 2.1 ± 1.6 | 2.2 ± 1.4 | 0.86 |
| Mean ± SD BMI (kg/m2) | 25.2 ± 3.2 | 23.7 ± 3.9 | 0.14 |
| Mean ± SD Console time (mins) | 107 ± 36 | 90 ± 37 | 0.12 |
| Mean ± SD DT (mins) | 84 ± 34 | 66 ± 35 | 0.04 |
| Mean ± SD WIT (mins) | 20.5 ± 5.2 | 20.9 ± 4.1 | 0.73 |
| Mean ± SD EBL (ml) | 93 ± 123 | 71 ± 52 | 0.62 |
| Mean ± SD tumor diameter (mm) | 32 ± 11 | 40 ± 10 | 0.01 |
| Mean ± SD R.E.N.A.L. score | 7.1 ± 1.9 | 7.3 ± 1.9 | 0.63 |
| Mean ± SD MAP score | 1.7 ± 1.6 | 2.2 ± 1.3 | 0.17 |
SD Standard deviation
Fig. 3Linear regressions between MAP score and dissection time (DT) of control a /GES b group respectively. Each circle in the figure represents an individual patient